1. Garg JP, Bakris GL. Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med. 2002;7(1):35‐43. [PubMed] [Google Scholar]

2. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity‐onset diabetes. N Engl J Med. 1984;310:356‐360. [PubMed] [Google Scholar]

3. Mojahedi MJ, Bonakdaran S, Hami M, Sheikhian MR, Shakeri MT, Aiatollahi H. Elevated serum c‐reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus. Iran J Kidney Dis. 2009;3(1):12‐16. [PubMed] [Google Scholar]

4. Tejani A, Phadke K, Adamson O, Nicastri A, Chen CK, Sen D. Renal lesions in sickle cell nephropathy in children. Nephron. 1985;39:352–355. doi: 10.1159/000183404. [PubMed] [CrossRef] [Google Scholar]

5. Eke CB, Okafor HV, Ibe BC. Prevalence and correlates of microalbuminuria in children with sickle cell anaemia: experience in a tertiary health facility in Enugu, Nigeria. Int J Nephrol. 2012;10:1152–1162. [PMC free article] [PubMed] [Google Scholar]

6. Keane WF, Eknoyan G. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis. 1999;33: 1004–1010. [PubMed] [Google Scholar]

7. Rademacher ER, Sinaiko AR. Albuminuria in children. Curr Opin Nephrol Hypertens. 2009;18: 246–251. doi: 10.1097/MNH.0b013e3283294b98 [PubMed] [Google Scholar]

8. Radhakishun NN, van Vliet M, von Rosenstiel IA, Beijnen JH, Diamant M. Limited value of routine microalbuminuria assessment in multi-ethnic obese children. Pediatr Nephrol. 2013;28: 1145–1149. doi: 10.1007/s00467-013-2451- 6 [PubMed] [Google Scholar]

9. Lurbe E, Torro MI, Alvarez J, Aguilar F, Fernandez-Formoso JA, Redon J. Prevalence and factors related to urinary albumin excretion in obese youths. J Hypertens. 2013;31: 2230–2236; discussion 2236. doi: 10.1097/HJH.0b013e328364bcbf [PubMed] [Google Scholar]

10. Ding W, Mak RH. Early markers of obesity-related renal injury in childhood. Pediatr Nephrol. 2015;30: 1 –4. doi: 10.1007/s00467-014-2976-3 [PubMed] [Google Scholar]

11. Goknar N, Oktem F, Ozgen IT, Torun E, Kucukkoc M, Demir AD, et al. Determination of early urinary renal injury markers in obese children. Pediatr Nephrol. 2015;30: 139–144. doi: 10.1007/s00467-014-2829-0 [PubMed] [Google Scholar]

12. Gerstein HC, Mann JF, Yi Q. Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421–426. doi: 10.1001/jama.286.4.421. [PubMed] [CrossRef] [Google Scholar]

13. Pinto-Sietsma SJ, Janssen WM, Hillege HL. Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol. 2000;11:1882–1888. [PubMed] [Google Scholar]

14. Pedrinelli R, Dell’Omo G, Di Bello V. Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension. J Hum Hypertens. 2002;16:79–89. doi: 10.1038/sj.jhh.1001316. [PubMed] [CrossRef] [Google Scholar]

15. Hillege HL, Fidler V, Diercks GF. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777–1782. doi: 10.1161/01.CIR.0000031732.78052.81. [PubMed] [CrossRef] [Google Scholar]

16. Solbu MD, Kronborg J, Jenssen TG. Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events. Atherosclerosis. 2009;204:503–508. doi: 10.1016/j.atherosclerosis.2008.11.002. [PubMed] [CrossRef] [Google Scholar]

17. Kshirsagar AV, Bomback AS, Bang H. Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004) Am J Cardiol. 2008;101:401–406. doi: 10.1016/j.amjcard.2007.08.041. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

18. Nakamura M, Onoda T, Itai K. Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Intern Med. 2004;43:919–925. doi: 10.2169/internalmedicine.43.919. [PubMed] [CrossRef] [Google Scholar]

19. Fox ER, Benjamin EJ, Sarpong DF. The relation of C-reactive protein to chronic kidney disease in African Americans:the Jackson Heart Study. BMC Nephrol. 2010;11:1. doi: 10.1186/1471 -2369-11-1. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

20. Festa A, D'Agostino RD, Howard G. Inflammation and microalbuminuria in nondiabetic and type 2diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int. 2000;58:1703–1710. doi: 10.1046/j.1523- 1755.2000.00331.x. [PubMed] [CrossRef] [Google Scholar]

21. Liping Jiang, Wen Huang, Yuanbo Liang, Fenghua Wang, Xinrong Duan, Xiaohui Yang, Jiangping Wen, Ningli Wang. Metabolic syndrome, C-reactive protein and microalbuminuria in a rural Chinese population: a cross-sectional study. BMC Nephrol. 2013; 14: 118. doi: 10.1186/1471-2369-14-118PubMed

22. Патогенетические механизмы формирования нефропатии при сахарном диабете 1 типа Л. В. Куценко, И. В. Зорин, А. А. Вялкова Для цитирования: Лечащий врач № 6/2018; Номера страниц в выпуске: 58-61

23. Дисметаболические нефропатии в практике педиатра/ А. В. Малкоч, Е. Г. Куликова, Ю. Б. Юрасова Для цитирования: Лечащий врач № 1/2019; Номера страниц в выпуске: 34-39

24. Зорин, И. В. Клинико-анамнестическая характеристика детей с пузырно-мочеточниковым рефлюксом и рефлюкс-нефропатией / И. В Зорин // Нефрология. – 2014. – Том 18. – №3. – С. 77–83.

25. Значение нарушений внутрипочечной гемодинамики в формировании тубу-лоинтерстициального поражения почек у детей. / И. В Зорин [и др.] // Лечащий Врач. – 2016. – №. 1. – С. 63–68.